Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Helioblock SX
- Development stage
- Phase 3
- Lead developer
- L'Oréal
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Helioblock SX is a sunscreen product containing ecamsule (Mexoryl SX) as its primary active ingredient, along with avobenzone, octocrylene, and titanium dioxide. It provides protection against both UVA and UVB rays to prevent sunburn. Pharmacokinetic studies show minimal systemic absorption of ecamsule following topical application.
- Brand names
- Helioblock SXAnthelios 40Anthelios40Anthelios-40Anthelios SP
- Other names
- Mexoryl SX Cream
Beyond the preview
Go deeper on Helioblock SX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Helioblock SX.